CHELMSFORD, Mass. — Brooks Automation, Inc. (Nasdaq: BRKS), a leading worldwide provider of automation and cryogenic solutions for multiple markets including semiconductor manufacturing and life sciences, today announced that Michael Rosenblatt, M.D. has been elected to its Board of Directors. Dr. Rosenblatt is the chief medical officer of Flagship Pioneering, a unique life sciences innovation enterprise, and […]
MILFORD, Mass.– Waters Corporation (NYSE: WAT) today announced that Linda Baddour, former Chief Financial Officer of PRA Health Sciences Inc., and Gary Hendrickson, former Chairman, President and Chief Executive Officer of Valspar Corporation, have been elected as Directors of Waters Corporationeffective September 1, 2018. “I am delighted to welcome both Linda Baddour and Gary Hendrickson to Waters Board of Directors,” said Chris O’Connell, Chairman and Chief Executive Officer, Waters […]
Further to the announcement on 26 July 2018, Spectris plc (SXS: LSE), the productivity-enhancing instrumentation and controls company (‘the Company’), is pleased to confirm that Andrew Heath has today joined the Board of the Company as Chief Executive Designate, ahead of his appointment as Chief Executive on 28 September 2018. Andrew will work with John […]
Emeryville, Calif. Berkeley Lights, Inc. (BLI), a leader in digital cell biology, announced today that Michel Sadelain, M.D., Ph.D., has been appointed a member of its Strategic Scientific Advisory Board (SSAB). Dr. Sadelain joins other renowned experts with deep domain knowledge and insight on the SSAB and provides a strategic resource as BLI continues to expand […]
Cambridge, United Kingdom – Congenica, the global provider of clinical genomics interpretation software, today announced the appointment of Mrs Wendy Britten as its new Chief Financial Officer (CFO), effective 1st September, 2018. Mrs Britten will have overall control and responsibility for all financial aspects of the business and will play a key role in business development […]
Basel Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Roland Diggelmann, CEO Diagnostics Division and member of the Corporate Executive Committee, will be leaving Roche to pursue his career outside of the company effective 30 September 2018. Until a successor is named, Michael Heuer, currently Region Head Europe, Middle East, Africa, and Latin America for […]
SARASOTA, Fla. — Roper Technologies, Inc. (NYSE: ROP), a leading diversified technology company, announced that Neil Hunn has been appointed President and Chief Executive Officer, effective September 1, 2018. Mr. Hunn is currently Roper’s Chief Operating Officer and has served as an Executive Vice President and Group Vice President since joining the Company in 2011. The […]
CFO Resigns to Pursue New Opportunity HOLLISTON, Mass. — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, today announced the resignation of Robert E. Gagnon, Chief Financial Officer, effective August 31, 2018. The Company has initiated a search for its next chief financial officer. […]
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Jeffrey W. Henderson has been elected to the company’s board of directors. Henderson, 53, is the non-executive chairman of the board of Qualcomm, Inc. and serves on the board of directors at FibroGen, Inc. and Halozyme Therapeutics, Inc. as well as serving as an advisory […]
San Diego, CA — Synthetic Genomics, Inc. (SGI), a leader in designing and programming biology for function, today announced J. Craig Venter, Ph.D., has retired from his longtime position as Chairman of the company’s Board of Directors to focus on his work at the J. Craig Venter Institute (JCVI). Dr. Venter will remain a Scientific […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
